This study demonstrates that p53 activates E3 ligase E6AP through direct interaction to induce ubiquitin-dependent proteasomal degradation of HBx, resulting in downregulation of HBx and subsequent inhibition of HBV replication in human hepatoma cells. Here, TP53 is linked to hepatocellular carcinoma.